FI109600B - Enantiomerseparering av cimaterol - Google Patents
Enantiomerseparering av cimaterol Download PDFInfo
- Publication number
- FI109600B FI109600B FI912151A FI912151A FI109600B FI 109600 B FI109600 B FI 109600B FI 912151 A FI912151 A FI 912151A FI 912151 A FI912151 A FI 912151A FI 109600 B FI109600 B FI 109600B
- Authority
- FI
- Finland
- Prior art keywords
- dibenzoyl
- amino
- tartaric acid
- ethanol
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
Claims (4)
1. Förfarande för framställning av (-)-l-(4,-amino-3'-cyanofenyl)-2-isopropyl-amino-etanol och (+)-l-(4,-amino-3'-cyanofenyl)-2-isopropylamino-etanol/ 5 kännetecknat därav, att l-(4,-amino-3'-cyanofenyl)-2-isopropylamino-etanol och ätminstone 2 ekvivalenter (-)-0,0'-dibensoyl-L-vinsyra eller (+)-Ο,Ο'-dibensoyl-D-vinsyra löses i metanol vid en temperatur över 20°C, det kristalliserade diastereomera saltet separeras, varefter den enantiomera ba-sen frigörs och vid behov därefter omvandlas den sä erhällna enantiomera 10 basen tili sitt fysiologiskt lämpliga syraadditionssalt.
2. Förfarande för framställning av l-(4'-amino-3'-cyanofenyl)-2-iso-propylamino-etanols diastereomera salter med (-)-0,0'-dibensoyl-L-vinsyra eller (+)-0,0'-dibensoyl-D-vinsyra, kännetecknat därav, att l-(4'-amino-3'- 15 cyanofenyl)-2-isopropylamino-etanol och ätminstone 2 ekvivalenter (-)-Ο,Ο'-dibensoyl-L-vinsyra eller (+)-0,0’-dibensoyl-D-vinsyra löses i metanol vid en temperatur över 20°C och det kristalliserade diastereomera saltet separeras. ; 20
3. Förfarande enligt patentkravet 1 eller 2, kännetecknat därav, att kristal- : · ·; liseringen utförs vid en temperatur över 25°C.
,4. Förfarande enligt patentkravet 1 eller 2, kännetecknat därav, att kristal-, liseringen utförs vid en temperatur mellan 25 - 30°C. 25 1 ·
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4014252 | 1990-05-04 | ||
DE4014252A DE4014252A1 (de) | 1990-05-04 | 1990-05-04 | Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer |
Publications (3)
Publication Number | Publication Date |
---|---|
FI912151A0 FI912151A0 (fi) | 1991-05-03 |
FI912151A FI912151A (fi) | 1991-11-05 |
FI109600B true FI109600B (sv) | 2002-09-13 |
Family
ID=6405664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI912151A FI109600B (sv) | 1990-05-04 | 1991-05-03 | Enantiomerseparering av cimaterol |
Country Status (27)
Country | Link |
---|---|
US (4) | US5248695A (sv) |
EP (2) | EP0589488B1 (sv) |
JP (1) | JP2944777B2 (sv) |
KR (1) | KR0183024B1 (sv) |
AR (1) | AR247728A1 (sv) |
AT (2) | ATE124932T1 (sv) |
AU (1) | AU645313B2 (sv) |
BG (1) | BG60743B1 (sv) |
CA (1) | CA2041818C (sv) |
CZ (1) | CZ286389B6 (sv) |
DE (3) | DE4014252A1 (sv) |
DK (2) | DK0589488T3 (sv) |
ES (2) | ES2109412T3 (sv) |
FI (1) | FI109600B (sv) |
GR (2) | GR3017064T3 (sv) |
HU (1) | HU214335B (sv) |
ID (1) | ID966B (sv) |
IE (2) | IE80651B1 (sv) |
IL (1) | IL98030A (sv) |
NO (1) | NO174803B (sv) |
NZ (1) | NZ238032A (sv) |
PT (1) | PT97544B (sv) |
RU (1) | RU2002737C1 (sv) |
SG (1) | SG45439A1 (sv) |
SK (1) | SK279258B6 (sv) |
TW (1) | TW197415B (sv) |
ZA (1) | ZA913337B (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4014252A1 (de) * | 1990-05-04 | 1991-11-07 | Boehringer Ingelheim Vetmed | Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer |
GB2289842B (en) * | 1991-04-05 | 1996-01-31 | Sepracor Inc | Improved use of ß2 bronchodilator drugs |
GB9107196D0 (en) * | 1991-04-05 | 1991-05-22 | Sandoz Ag | Improvements in or relating to organic compounds |
AU2247997A (en) * | 1996-01-29 | 1997-08-20 | Savor, Evelyn P. | Method of treating undesired uterine contractions using optically pure R-or RR-isomers of adrenergic beta-2 agonists |
EP1787529A3 (en) * | 1997-04-30 | 2009-11-18 | Courage Corporation Pty Ltd. | Composition and methods using an eutomer |
AU737608B2 (en) | 1997-04-30 | 2001-08-23 | Courage Corporation Pty Ltd | Composition and methods using an eutomer |
ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
US7232837B2 (en) | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
WO2001083462A1 (de) * | 2000-04-27 | 2001-11-08 | Boehringer Ingelheim Pharma Kg | Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel |
US20030162459A1 (en) * | 2002-02-27 | 2003-08-28 | Osbon Robert Lindsay | Method for producing a nonwoven fabric with enhanced characteristics |
US20040235922A1 (en) * | 2003-05-15 | 2004-11-25 | Baile Clifton A. | Compositions and methods for inducing adipose tissue cell death |
CA2526586C (en) | 2003-09-09 | 2010-03-16 | Fumapharm Ag | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
SG124283A1 (en) * | 2004-03-24 | 2006-08-30 | Trusted Hub Ltd | Document signature method & system |
RS51464B (en) | 2005-04-13 | 2011-04-30 | Astion Development A/S | BETA-2 ADRENOCEPTOR AGONISTS FOR TREATMENT OF DISEASES OF THE SKIN TISSUE TISSUE |
WO2006128180A2 (en) * | 2005-05-27 | 2006-11-30 | Children's Medical Center Corporation | Methods for the treatment of disease |
WO2006138243A2 (en) * | 2005-06-13 | 2006-12-28 | University Of Vermont And State Agricultural College | Inhibition of creatine uptake to promote weight loss |
CN104854093B (zh) | 2012-12-03 | 2016-10-12 | 辉瑞大药厂 | 新的选择性雄激素受体调节剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL136601C (sv) * | 1967-06-15 | |||
US4119710A (en) * | 1972-12-18 | 1978-10-10 | Boehringer Ingelheim Gmbh | Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts |
US4407819A (en) * | 1980-08-25 | 1983-10-04 | American Cyanamid Company | Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals |
US4814350A (en) * | 1986-09-10 | 1989-03-21 | American Cyanamid Company | Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile |
US4792546A (en) * | 1986-12-05 | 1988-12-20 | American Cyanamid Company | Method for increasing weight gains and reducing deposition of fat in animals |
DE4014252A1 (de) * | 1990-05-04 | 1991-11-07 | Boehringer Ingelheim Vetmed | Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer |
-
1990
- 1990-05-04 DE DE4014252A patent/DE4014252A1/de not_active Withdrawn
-
1991
- 1991-04-26 DE DE59105957T patent/DE59105957D1/de not_active Expired - Fee Related
- 1991-04-26 DK DK93117935.2T patent/DK0589488T3/da active
- 1991-04-26 DE DE59108853T patent/DE59108853D1/de not_active Expired - Fee Related
- 1991-04-26 ES ES93117935T patent/ES2109412T3/es not_active Expired - Lifetime
- 1991-04-26 SG SG1996008586A patent/SG45439A1/en unknown
- 1991-04-26 ES ES91106774T patent/ES2075255T3/es not_active Expired - Lifetime
- 1991-04-26 EP EP93117935A patent/EP0589488B1/de not_active Expired - Lifetime
- 1991-04-26 DK DK91106774.2T patent/DK0455155T3/da active
- 1991-04-26 AT AT91106774T patent/ATE124932T1/de not_active IP Right Cessation
- 1991-04-26 AT AT93117935T patent/ATE158277T1/de not_active IP Right Cessation
- 1991-04-26 EP EP91106774A patent/EP0455155B1/de not_active Expired - Lifetime
- 1991-04-29 AU AU76111/91A patent/AU645313B2/en not_active Ceased
- 1991-04-30 US US07/693,760 patent/US5248695A/en not_active Expired - Fee Related
- 1991-05-01 TW TW080103440A patent/TW197415B/zh active
- 1991-05-02 IL IL9803091A patent/IL98030A/en not_active IP Right Cessation
- 1991-05-02 PT PT97544A patent/PT97544B/pt not_active IP Right Cessation
- 1991-05-02 JP JP3100832A patent/JP2944777B2/ja not_active Expired - Fee Related
- 1991-05-02 KR KR1019910007085A patent/KR0183024B1/ko not_active IP Right Cessation
- 1991-05-03 NO NO911746A patent/NO174803B/no not_active IP Right Cessation
- 1991-05-03 ZA ZA913337A patent/ZA913337B/xx unknown
- 1991-05-03 CA CA002041818A patent/CA2041818C/en not_active Expired - Fee Related
- 1991-05-03 AR AR91319603A patent/AR247728A1/es not_active Expired - Lifetime
- 1991-05-03 HU HU911502A patent/HU214335B/hu not_active IP Right Cessation
- 1991-05-03 CZ CS19911292A patent/CZ286389B6/cs not_active IP Right Cessation
- 1991-05-03 NZ NZ238032A patent/NZ238032A/en unknown
- 1991-05-03 BG BG94342A patent/BG60743B1/bg not_active Expired - Lifetime
- 1991-05-03 IE IE950792A patent/IE80651B1/en not_active IP Right Cessation
- 1991-05-03 FI FI912151A patent/FI109600B/sv not_active IP Right Cessation
- 1991-05-03 IE IE150791A patent/IE69017B1/en not_active IP Right Cessation
- 1991-05-03 SK SK1292-91A patent/SK279258B6/sk unknown
- 1991-12-18 RU SU915010409A patent/RU2002737C1/ru not_active IP Right Cessation
-
1992
- 1992-01-31 ID IDP198592A patent/ID966B/id unknown
-
1993
- 1993-06-23 US US08/081,996 patent/US5292753A/en not_active Expired - Fee Related
- 1993-12-14 US US08/166,584 patent/US5395957A/en not_active Expired - Lifetime
-
1994
- 1994-11-29 US US08/346,105 patent/US5648386A/en not_active Expired - Fee Related
-
1995
- 1995-08-09 GR GR950402190T patent/GR3017064T3/el unknown
-
1997
- 1997-12-02 GR GR970403196T patent/GR3025547T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI109600B (sv) | Enantiomerseparering av cimaterol | |
US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
CN101643469B (zh) | 一种盐酸巴尼地平的合成工艺 | |
SK512004A3 (en) | Process for the preparation of racemic citalopram and/or S- or R-citalopram by separation of a mixture of R- and S-citalopram | |
US7358374B2 (en) | Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene | |
USRE29588E (en) | Preparation of d-2-amino-1-butanol salts | |
DE69813729T3 (de) | Verfahren zur Herstellung von 1-(9'H-Carbazol-4'yloxy)-3-2''-(2'''-methoxy-phenoxy)ethyl)-amino)-2-ol (Carvedilol) und Zwischenverbindungen | |
US20080076825A1 (en) | Novel Crystalline Forms of Entacapone and Production Thereof | |
JPS6187667A (ja) | 光学的活性アミンの製造方法 | |
JP2004511476A (ja) | R(+)α−リポ酸の製造方法 | |
EP2197273B1 (en) | Process for preparing r-gossypol l-phenylalaninol dienamine | |
US3931184A (en) | Purification method for prolyl-leucylglycinamide | |
CA2742725A1 (en) | Process for resolving zopiclone | |
GB1580001A (en) | Therapeutically active 1 - phenyl - 1 - methoxy - 2-aminothane derivatives | |
US20070276137A1 (en) | Process For The Resolution Of Nefopam | |
US20070054960A1 (en) | Sertraline acid addition salt, its preparation and its use in the preparation of sertraline hydrochloride form II | |
US7368607B2 (en) | Toremifene crystallization method | |
US2841609A (en) | Dextro-6-dimethylamino-4, 4-diphenyl-5-methyl-3-hexanone, salts thereof, and preparation thereof | |
JPH05502027A (ja) | R(+) ―テロジリン及びそれらの塩の製造方法 | |
NO131279B (sv) | ||
EP2177221A1 (en) | Process for the preparation of substantially optically pure Repaglinide and precursors thereof | |
FR2633617A1 (fr) | Nouveaux derives du benzocycloheptene, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
JPS59216887A (ja) | テトラヒドロ−1H−ピラゾロ〔5,1−a〕イソインド−ル | |
BE671781A (sv) | ||
CH634298A5 (en) | Process for preparing phenylazacycloalkanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |